Thomas Jefferson University
  • Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.

D'Amico M, Wu K, Di Vizio D, Reutens AT, Stahl M, Fu M, Albanese C, Russell RG, Muller WJ, White M, Negassa A, Lee HW, DePinho RA, Pestell RG. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis. Cancer Res. 2003 Jun 15; 63(12):3395-402.

View in: PubMed

subject areas
  • Adenocarcinoma
  • Aneuploidy
  • Animals
  • Apoptosis
  • Breast Neoplasms
  • Cell Cycle
  • Cell Transformation, Neoplastic
  • Cell Transformation, Viral
  • Crosses, Genetic
  • Cyclin D1
  • Cyclin-Dependent Kinase Inhibitor p16
  • Female
  • Gene Expression Regulation, Neoplastic
  • Genes, erbB-2
  • Genes, p16
  • Genetic Predisposition to Disease
  • Heterozygote
  • Humans
  • Ki-67 Antigen
  • Mammary Neoplasms, Experimental
  • Mammary Tumor Virus, Mouse
  • Mice
  • Mice, Knockout
  • Mice, Transgenic
  • Organ Specificity
  • Transfection
  • Tumor Suppressor Protein p14ARF

authors with profiles
  • Kongming Wu
  • Richard Pestell



Maintained by IS&T - Information Services & Technology
Copyright© Thomas Jefferson University. All Rights Reserved.

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement